Podcast Index
Parcourez les podcasts par catégorie, ouvrez les épisodes récents et téléchargez l’audio pour l’écouter hors ligne.
Science Fiction Library
The Podcast Network
You Are Good
Alex Steed
RTL soir
RTL
Busted Open
SiriusXM
Serial Killer Podcast Documentary
Peter Jesse
The Intersection with Michael Popok
MeidasTouch Network
The Vince Everett Ellison Show
Media Squatch
Real Coffee with Scott Adams
Scott Adams
Sentido Saúde, com Dr. Ricardo Guimarães
Band Minas
SEGA SATURN, SHIRO!
SHIRO! MEDIA GROUP
PL Podcast
Paislobo Prensa
Veterinary Podcast by the VetGurus
Brendan Carmel and Mark Simpson
Abraham Hicks
Abraham Hicks
Oh, Anna!
The Fellas Studios
Gary Parrish Show
Grind City Media
The Style Stories Podcast
Personal Stylist Lisa Gillbe
Sabres Live
Audacy
Decera Clinical Education Oncology Podcast
Decera Clinical Education
Notre Dame Fighting Irish Football Today | 2 Min News | The Daily News Now!
The Daily News Now!
Bloomberg Intelligence
Bloomberg
Paul’s Best Podcast
iHeartPodcasts
sarah marie anderson's podcast
sarah marie anderson
Daily Fantasy Sports by Ship It Nation
Ship It Nation
رادیو فردا
رادیوفردا
Binge Buddies
After the Hype
Audio Poem of the Day
Poetry Foundation
Automotive News Daily Drive
Automotive News
Seattle News, Views, and Brews
Brian Callanan
Talking Real Money - Investing Talk
Don McDonald
Thy Strong Word from KFUO Radio
KFUO Radio
DLWeekly Podcast - Disneyland News and Information
DLWeekly, Bleav
Choses à Savoir TECH
Choses à Savoir
Wrobel - Der Tucholsky-Podcast
Frank Dittmer
Daily Mitzvah (Rambam)
Chabad.org: Berel Bell
Locked On White Sox - Daily Podcast On The Chicago White Sox
Locked On Podcast Network, Jim Memolo
The Joe Rogan Experience
Joe Rogan
Tout
Decera Clinical Education
In this podcast episode, Natalie S. Callander, MD, and Tom Martin, MD, discuss the optimal approaches for the determination of whether a patient with high-risk SMM requires treatment or observation, including: Contempo...
Listen in to learn from Thomas Bachelot, MD, PhD, and Mafalda Oliveira, MD, PhD, about recent advances and the integration of anti-TROP2 antibody-drug conjugates (ADCs) into the management of patients with triple-negativ...
In this episode, Dr Sara Ann Scott and Dr Syeda Saba Kareem discuss toxicities and the safe management of bispecific antibodies used in the treatment of RRMM to improve outcomes for patients, including: The incidence o...
In this episode, Dr Paul E. Oberstein, Dr Andrew H. Ko, and Dr Efrat Dotan discuss recent advances in pancreatic cancer, including: The evolving role of chemotherapy Utility of tumor treating fields for the treatment ...
Treatment options for patients with multiple myeloma are rapidly evolving. In this podcast episode, Jesus Berdeja, MD, and Amrita Krishnan, MD, FCAP, discuss GPRC5D-directed treatment options for patients with relapsed/r...
In this podcast episode, Donald Moore, PharmD, BCPS, BCOP, DPLA, FCCP, FASHP, and Anthony Perissinotti, PharmD, BCOP, discuss the role, efficacy, and safety of agents targeting BCMA in the personalized care of patients w...
Listen in to learn from Cristina Saura Manich, MD, PhD and Giampaolo Bianchini, MD about practical approaches to PI3K pathway testing, PI3K/AKT-targeted treatment options, and endocrine-based sequencing in metastatic bre...
Link to claim CME credit: https://bit.ly/4uRr3ir In this episode, Elizabeth Krueger, NP, and Sam Vafadar, DHSc, PA-C, discuss how they optimize first-line EGFR-targeted therapy for patients with EGFR-mutated NSCLC, inclu...
In this episode, Dr Abbie Begnaud discusses the importance of lung cancer screening and evolving strategies to improve early detection among high-risk populations, including: Low-dose CT screening, which reduces lung c...
In this episode, Aarti Bhatia, MD, MPH, and Deborah J. Wong, MD, PhD, discuss the rapidly evolving treatment landscape for recurrent, metastatic, and locally advanced head and neck squamous cell carcinoma (HNSCC), incl...
In this episode, hear Doris K. Hansen, MD, discuss the management of relapsed/refractory multiple myeloma with bispecific antibodies including: Practical differences among approved bispecific antibodies Toxicity profi...
In this episode, Muhamed Baljevic, MD, FACP, and Johnathan Ticku, MD, discuss various strategies to optimize the use of bispecific antibodies in their practices for the treatment of R/R MM through patient monitoring, dos...
In this episode, hear Anthony Hunter, MD and Douglas Tremblay, MD discuss the various presentations of thrombotic events in patients with PV or ET including how thrombotic events may lead to diagnosis: PV and ET incre...
In this podcast episode, Ciro Rinaldi MD, PhD, and Alessandro M. Vannucchi, MD, discuss contemporary management of essential thrombocythemia (ET) and polycythemia vera (PV), as well as novel investigational approaches, i...
In this podcast episode, Ciro Rinaldi, MD, PhD, and Alessandro M. Vannucchi, MD, as they discuss contemporary topics in diagnosing essential thrombocythemia (ET) and polycythemia vera (PV), including: Overview of diagn...
In this podcast episode, Erika Hamilton, MD, FASCO, and Ian Krop, MD, PhD, discuss recent developments in the field of first-line therapy and maintenance treatment for patients with HER2-positive metastatic breast cancer...
A patient advocate/cancer survivor and a healthcare professional discuss key topics including early breast cancer diagnosis, role of self-agency in pursuing optimal cancer care, encouraging trial participation with patie...
Podcast with global experts discussing the role of AKT and PI3K inhibitors in patients with resistance to endocrine therapy in the adjuvant or metastatic disease settings following current guidelines, indications, and be...
In this episode, Danielle Roman, PharmD, BCOP, and Jordan Hill, PharmD, BCOP, discuss patient-centered management of CDK4/6 inhibitor therapy in HR-positive/HER2-negative breast cancer, with a focus on how oncology pharm...
In this episode, Dr Matthew Gubens and Dr Helena Yu discuss the evolving role of TROP2-directed therapies in non-small-cell lung cancer, with a focus on how antibody–drug conjugates (ADCs) fit into current treatment stra...
Remplissez le formulaire ci-dessous. Veillez à sélectionner à la fois Pays et Genres.
Envoyez-nous un message ci-dessous. Nous vous répondrons dans les 24 heures.